Biological Products

"Biological Products" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Complex pharmaceutical substances, preparations, or matter derived from organisms usually obtained by biological methods or assay.

Descriptor ID	D001688
MeSH Number(s)	D20.215
Concept/Terms	Biological Products Biological Products Biologic Products Products, Biologic Biologics Products, Biological Natural Products Natural Products Products, Natural

Below are MeSH descriptors whose meaning is more general than "Biological Products".

Chemicals and Drugs [D]
Complex Mixtures [D20]
Biological Products [D20.215]

Below are MeSH descriptors whose meaning is related to "Biological Products".

Below are MeSH descriptors whose meaning is more specific than "Biological Products".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Biological Products" by people in this website by year, and whether "Biological Products" was a major or minor topic of these publications.

Bar chart showing 79 publications over 19 distinct years, with a maximum of 11 publications in 2024

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1997	1	0	1
2002	1	0	1
2006	1	0	1
2008	2	1	3
2009	1	0	1
2010	1	2	3
2011	2	0	2
2012	3	0	3
2013	4	1	5
2015	5	0	5
2016	4	2	6
2017	3	0	3
2018	7	0	7
2019	4	0	4
2020	5	1	6
2021	2	0	2
2022	10	0	10
2023	5	0	5
2024	7	4	11

Below are the most recent publications written about "Biological Products" by people in Profiles.

Cleveland NK, Ghosh S, Kathe N, Umashankar K, Mirchandani K, Hait A, Paul R, Candela N, Fan T, Rubin DT. Dose escalation of biologics in biologic-naive patients with Crohn's disease: Outcomes from the ODESSA-CD study. J Manag Care Spec Pharm. 2024 Nov; 30(11):1276-1287.

View in: PubMed
Krugliak Cleveland N, Ghosh S, Chastek B, Bancroft T, Candela N, Fan T, Umashankar K, Rubin DT. Real-World Persistence of Successive Biologics in Patients With Inflammatory Bowel Disease: Findings From ROTARY. Inflamm Bowel Dis. 2024 Oct 03; 30(10):1776-1787.

View in: PubMed
Krugliak Cleveland N, Ghosh S, Chastek B, Bancroft T, Candela N, Fan T, Umashankar K, Rubin DT. Evaluation of adverse clinical outcomes in patients with inflammatory bowel disease receiving different sequences of first- and second-line biologic treatments: findings from ROTARY. BMC Gastroenterol. 2024 Sep 17; 24(1):314.

View in: PubMed
Huang YC, Lee NY, Weng MY. Increased risk of Pneumocystis jirovecii colonization in rheumatoid arthritis patients on biologics and Janus kinase inhibitor. J Microbiol Immunol Infect. 2025 Feb; 58(1):112-119.

View in: PubMed
Pappas DA, Reed G, Kane K, Curtis JR, Charles-Schoeman C, Giles JT, Kremer JM. Effect of biologic agents and inflammation on lipid levels and cardiovascular risk in rheumatoid arthritis patients. Semin Arthritis Rheum. 2024 Oct; 68:152504.

View in: PubMed
Shridharmurthy D, Lapane KL, Baek J, Nunes AP, Weisman MH, Kay J, Liu SH. Sex Differences in Time to Initiate Nonsteroidal Anti-Inflammatory Drugs or Biologic Disease-Modifying Antirheumatic Drugs Among Patients With Axial Spondyloarthritis. Arthritis Care Res (Hoboken). 2024 08; 76(8):1149-1161.

View in: PubMed
Karadkhelkar NM, Gupta P, Barasa L, Chilamakuri R, Hlordzi CK, Acharekar N, Agarwal S, Chen ZS, Yoganathan S. Chemical Derivatization Leads to the Discovery Of Novel Analogs of Azotochelin, a Natural Siderophore, as Promising Anticancer Agents. ChemMedChem. 2024 Jul 02; 19(13):e202300715.

View in: PubMed
Aripova N, Kremer JM, Pappas DA, Reed G, England BR, Robinson BH, Curtis JR, Thiele GM, Mikuls TR. Anti-citrullinated protein antibody profiles predict changes in disease activity in patients with rheumatoid arthritis initiating biologics. Rheumatology (Oxford). 2024 02 01; 63(2):542-550.

View in: PubMed
Mease PJ, Blachley T, Malatestinic WN, Harrold LR, Dube B, Lisse JR, Bolce RJ, Hunter TM. Effectiveness of bDMARDs in ankylosing spondylitis patients by biologic use: experience from the CorEvitas PsA/SpA Registry. Curr Med Res Opin. 2024 02; 40(2):315-323.

View in: PubMed
Harrold LR, Wittstock K, Kelly S, Han X, Zhuo J, Schrader A, Middaugh N, Moore PC, Khaychuk V. Comparative effectiveness of abatacept versus TNF inhibitors in rheumatoid arthritis patients who are ACPA and shared epitope positive. Adv Rheumatol. 2024 01 19; 64(1):10.

View in: PubMed

People

Explore

Similar Concepts

Top Journals